AIM ImmunoTech Inc. Common Stock (AIM)

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill · April 13, 2026

What's Going On With AIM ImmunoTech Stock Friday?benzinga.com

AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments.

Via Benzinga · March 20, 2026

Which stocks are moving on Wednesday?chartmill.com

Via Chartmill · March 18, 2026

Here are the top movers in Wednesday's session.chartmill.com

Via Chartmill · March 18, 2026

Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com

Via Chartmill · March 18, 2026

Discover the top movers in Wednesday's pre-market session.chartmill.com

Via Chartmill · March 18, 2026

Why Did AIM Stock More Than Double In Pre-Market Today?stocktwits.com

The company said that a patent using its proprietary cancer treatment method was fully approved in Japan.

Via Stocktwits · March 18, 2026

Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com

Via Chartmill · February 19, 2026

Tuesday's pre-market session: top gainers and loserschartmill.com

Via Chartmill · February 17, 2026

Here are the top movers in Thursday's session.chartmill.com

Via Chartmill · February 5, 2026

Gapping stocks in Thursday's sessionchartmill.com

Via Chartmill · February 5, 2026